BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Russian Biotechnology Company BIOCAD Prepares to Enters the European Market

  The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines.

  October 25, 2017

   · 

  3 min read
• Business

  Myriad to Announce Fiscal First-Quarter 2018 Financial Results on November 7, 2017

  The CEO and CFO will provide an overview of Myriad’s financial performance for the fiscal first-quarter and provide a business update.

  October 25, 2017

   · 

  2 min read
• Pharm Country

  Provista Diagnostics’ New Study: Videssa Breast Blood Test Can Effectively Rule Out Breast Cancer, Regardless of Breast Density

  A new study published in PLOS ONE demonstrates that Videssa Breast, a multi-protein biomarker blood test for breast cancer by Provista Diagnostics, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

  October 25, 2017

   · 

  5 min read
• Business

  Alzamend Neuro Launches Pursuit to Secure FDA IND and First Stage Clinicals

  The company has selected TAMM Net as FDA consultant to lead regulatory actions for USF treatment.

  October 25, 2017

   · 

  6 min read
• Business

  Idera Pharmaceuticals Provides Corporate Governance Update

  Youssef El Zein, Managing Partner of Pillar Invest Corporation has elected to step down from the company’s Board of Directors, effective immediately.

  October 25, 2017

   · 

  4 min read
• Business

  Notal Vision Welcomes Distinguished Retinal Specialist John S. Pollack, MD, to the Board of Directors

  Notal Vision today announced that John S. Pollack, MD, an internationally recognized retinal clinician, surgeon, and educator, has been elected to Notal’s Board of Directors.

  October 25, 2017

   · 

  4 min read
• Business

  3D Signatures Reports Financial Results for 2017

  The Company recorded a net loss of $9,913,401 in the year ended June 30, 2017 and $1,758,719 in the year ended June 30, 2016.

  October 25, 2017

   · 

  11 min read
• Business

  Epizyme Announces Date of Third Quarter 2017 Financial Results

  The webcast can be accessed under “Events and Presentations” in the Investor Relations section of the company’s website

  October 25, 2017

   · 

  1 min read
• CorFlow Completes the First Close of the Seed+ Financing Round

  CorFlow Therapeutics AG today announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by experienced private medical device investors who over the last decades have supported breakthrough interventional cardiology technologies.

  October 25, 2017

   · 

  2 min read
• Nexstim Raises EUR 1.75 Million Via a Directed Issue of New Shares to London-Based Investor City Financial - Funds to be Used to Support Beginning The Commercialisation of Its NBT System

  The new shares are expected to be registered with the Finnish Trade Register on or about 30 October 2017.

  October 25, 2017

   · 

  3 min read